Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission.

Bone Marrow Transplant

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Published: September 2019

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708776	PMC
http://dx.doi.org/10.1038/s41409-019-0481-9	DOI Listing

Publication Analysis

pre-transplant bone

bone marrow

marrow monocytic

monocytic myeloid-derived

myeloid-derived suppressor

suppressor cell

cell frequency

frequency associated

associated outcome

outcome allogeneic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!